期刊文献+

促血管生成素-1腺病毒表达载体构建及鉴定 被引量:4

Construction and identification of adenovirus expression vector modified by Angiopoietin-1
下载PDF
导出
摘要 目的构建表达促血管生成素-1(Ang-1)的腺病毒载体,为研究Ang-1防治慢性缺血性疾病提供前期基础。方法通过PCR从pMD18-Ang-1质粒中扩增Ang-1基因,酶切连接入载体pDC315-GFP并转化大肠杆菌感受态细胞,PCR鉴定测序分析;借助AdMax腺病毒包装系统实现重组,提取质粒DNA并转染HEK293细胞,观察GFP荧光并以Western Blot检测目的蛋白的表达,以终点稀释法测定病毒滴度。结果重组质粒pDC315-GFP-Ang-1经PCR鉴定阳性克隆,测序分析比对正确,重组腺病毒转染HEK293细胞后可观察到GFP-Ang-1融合蛋白,病毒滴度1×1011PFU/ml。结论成功构建了表达Ang-1基因的腺病毒载体。 Objective This study was designed to construct a adenovirus vector that expresses angiopoietin-1(Ang-1) gene with recombinant DNA technology,and lays the basis for the following study on Ang-1 prevention and cure of chronic ischmic diseases.Methods Ang-1 gene was amplified from plasmid pMD18-Ang-1 with polymerase chain reaction(PCR).The fragment was inseted to shuttle plasmid pDC315-GFP by digesting with restrictive enzymes and linking reactions.The recombinant plasmid was transformed into E.coli DH5α,and identified with PCR and sequence analysis.The plasmid DNA extracted from AdMax auxiliary packaging system was co-transfect to HEK293 cells.The expression of GFP fluorescence and Ang-1 protein were detected by fluorescence microscope and Western blot.The titer of recombinant adenovirus was detected with end-point dilution method.Results The positive recombinant plasmid pDC315-GFP-Ang-1 was successfully screened by PCR,and the sequence of Ang-1 gene was further confirmed.The expression of GFP fluorescence and Ang-1 protein were found in HEK293 cells transfected with recombinant plasmid.The titer of recombinant adenovirus was about 1×1011PFU/ml.Conclusion The adenovirus vector expressing Ang-1 gene is successfully constructed.
出处 《遵义医学院学报》 2011年第5期465-468,共4页 Journal of Zunyi Medical University
基金 贵州省优秀科技教育人才省长专项资金项目(NO:黔省专合字[2005]242) 遵义医学院博士科研启动基金项目(NO:[2006]13)
关键词 促血管生成素-1 腺病毒载体 基因工程 Angiopoietin-1 Adenovirus vector gene engineering
  • 相关文献

参考文献6

  • 1黄颂敏,陈泽君,杨亦彬,付平,柳飞,张翥,苏克亮.血管生成素及其受体、血管内皮生长因子与糖尿病肾脏微血管病变的关系[J].中华肾脏病杂志,2006,22(9):521-527. 被引量:26
  • 2Lerman LO, Chade AR. Angiogenesis in the kidney: a new therapeutic target[J]? Curr Opin Nephrol Hypertens, 2009,18(2):160-165.
  • 3Maeshima Y, Makino H.Angiogenesis and chronic kidney disease[J].Fibrogenesis Tissue Repair,2010, 5 (3):13.
  • 4Adrian S,WoolfAS,Gnudi L.et al. Roles of Angiopoietins in kidney development and disease [J]. .1 Am Soc Nephrol,2009, 20(2):239-244.
  • 5Jonathan E,Jisen D,Jing W, et al. Effects of cellular iron deficiency on the formation of vascular endothelial growth factor and angiogenesis.lron deficiency and angiogenesis[J].Cancer Cell lnt,2010, 19(10):28.
  • 6孟国林,段春光,刘建,吕昌伟,杨旻,袁志,胡蕴玉.血管生成素1和报告基因EGFP双基因共表达腺病毒的构建[J].第四军医大学学报,2008,29(11):1002-1004. 被引量:2

二级参考文献21

  • 1Flyvbjerg A.Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease.Diabetologia,2000,43:1205-1223.
  • 2Yancopoulos GD,Davis S,Gale NW,et al.Vascular-specific growth factors and blood vessel formation.Nature,2000,407(6801):242-248.
  • 3Abdulmalek K,Ashur F,Ezer N,et al.Differential expression of Tie-2 receptors and angiopoietins in response to in vivo hypoxia in rats.Am J Physiol Lung Cell Mol Physiol,2001,281:L582-L590.
  • 4Yamamoto Y,Maeshima Y,Kitayama H,et al.Tumstatin peptide,an inhibitor of angiogenesis,prevents glomerular hypertrophy in the early stage of diabetic nephropathy.Diabetes,2004,53:1831-1840.
  • 5Osterby R,Asplund J,Bangstad HJ,et al.Neovascularization at the vascular pole region in diabetic glomerulopathy.Nephrol Dial Transplant,1999,14:348-352.
  • 6Satchell SC,Mathieson PW.Angiopoietins:microvascular modulators with potential roles in glomerular pathophysiology.J Nephrol,2003,16:168-178.
  • 7Padro T,Ruiz S,Bieker R,et al.Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia.Blood,2000,95:2637-2644.
  • 8Khamaisi M,Schrijvers BF,De Vriese AS,et al.The emerging role of VEGF in diabetic kidney disease.Nephrol Dial Transplant,2003,18:1427-1430.
  • 9Thurston C,Suri C,Smith K,et al.Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1.Science,1999,286(5449):2511-2514.
  • 10Enholm B,Paavonen K,Ristimaki A,et al.Comparison of VEGF,VEGF-B,VEGF-C and Ang-1 mRNA regulation by serum,growth factors,oncoproteins and hypoxia.Oncogene,1997,14:2475 -2483.

共引文献26

同被引文献24

  • 1Karalliedde J,Gnudy L.Endothelial factors and diabetic nephropathy.Diabetes Care,2011,34(Suppl 2):S291-S296.
  • 2Nakagawa T,Kosugi T,Haneda M,et al.Abnormal angiogenesis in diabetic nephropathy.Diabetes,2009,58:1471-1478.
  • 3Ueda S,Yamagishi SI,Okuda S.Anti-vasopermeability effects of PEDF in retinal-renal disorders.Curr Mol Med,2010,10:279-283.
  • 4Lawler PR,Lawler J.Molecular basis for the regulation of angiogenesis by thrombospondin-1 and-2.Cold Spring Harb Perspect Med,2012,2:1-13.
  • 5Wang JJ,Zhang SX,Lu K,et al.Decreased expression of pigment epithelium derived factor is involved in the pathogenesis of diabetic nephropathy.Diabetes,2005,54:243-250.
  • 6Hohenstein B,Daniel C,Hausknecht B,et al.Correlation of enhanced thrombospondin-1 expression,TGF-beta signalling and proteinuria in human type 2 diabetic nephropathy.Nephrol Dial Transplant,2008,23:3880-3887.
  • 7Sakai K,Sumi Y,Muramatsu H,et al.Thrombospondin-1 promotes fibroblast-mediated collagen gel contraction caused by activation of latent transforming growth factor beta-1.J Dermatol Sci,2003,31:99-109.
  • 8Samuel SM,Akita Y,Paul D,et al.Coadministration of adenoviral vascular endothelial growth factor and angiopoietin-1 enhances vascularization and reduces ventricular remodeling in the infarcted myocardium of type 1 diabetic rats.Diabetes,2010,59:51-60.
  • 9Lee S,Kim W,Moon SO,et al.Renoprotective effect of COMP-angiopoietin-1 in db/db mice with type 2 diabetes.Nephrol Dial Transplant,2007,22:396-408.
  • 10Joussen AM,Poulaki V,Tsujikawa A,et al.Suppression of diabetic retinopathy with angiopoietin-1.Am J Pathol,2002,160:1683-1693.

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部